RS59021B1 - Postupak za proizvodnju derivata hidroksietil skroba - Google Patents

Postupak za proizvodnju derivata hidroksietil skroba

Info

Publication number
RS59021B1
RS59021B1 RS20190850A RSP20190850A RS59021B1 RS 59021 B1 RS59021 B1 RS 59021B1 RS 20190850 A RS20190850 A RS 20190850A RS P20190850 A RSP20190850 A RS P20190850A RS 59021 B1 RS59021 B1 RS 59021B1
Authority
RS
Serbia
Prior art keywords
value
temperature
solution
iron
hydroxyethyl starch
Prior art date
Application number
RS20190850A
Other languages
English (en)
Serbian (sr)
Inventor
Werner Zimmermann
Jan Lukowczyk
Original Assignee
Serumwerk Bernburg Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44799422&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS59021(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Serumwerk Bernburg Ag filed Critical Serumwerk Bernburg Ag
Publication of RS59021B1 publication Critical patent/RS59021B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/08Ethers
    • C08B31/12Ethers having alkyl or cycloalkyl radicals substituted by heteroatoms, e.g. hydroxyalkyl or carboxyalkyl starch
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/08Ethers
    • C08B31/10Alkyl or cycloalkyl ethers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/18Oxidised starch
    • C08B31/185Derivatives of oxidised starch, e.g. crosslinked oxidised starch

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RS20190850A 2011-06-21 2012-06-21 Postupak za proizvodnju derivata hidroksietil skroba RS59021B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11170761A EP2537866A1 (en) 2011-06-21 2011-06-21 Hydroxyethyl starch derivatives, method for manufacturing the same and therapeutical uses thereof
PCT/EP2012/061958 WO2012175608A1 (en) 2011-06-21 2012-06-21 Method for manufacturing hydroxyethyl starch derivatives
EP12737229.0A EP2723774B1 (en) 2011-06-21 2012-06-21 Method for manufacturing hydroxyethyl starch derivatives

Publications (1)

Publication Number Publication Date
RS59021B1 true RS59021B1 (sr) 2019-08-30

Family

ID=44799422

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20190850A RS59021B1 (sr) 2011-06-21 2012-06-21 Postupak za proizvodnju derivata hidroksietil skroba

Country Status (22)

Country Link
US (2) US9181353B2 (enExample)
EP (2) EP2537866A1 (enExample)
JP (2) JP6370217B2 (enExample)
CN (2) CN103649128B (enExample)
BR (1) BR112013032901A2 (enExample)
CA (1) CA2837784C (enExample)
CY (1) CY1121976T1 (enExample)
DK (1) DK2723774T3 (enExample)
ES (1) ES2733767T3 (enExample)
HK (1) HK1220218A1 (enExample)
HR (1) HRP20191173T1 (enExample)
HU (1) HUE044428T2 (enExample)
LT (1) LT2723774T (enExample)
MX (1) MX337682B (enExample)
PL (1) PL2723774T3 (enExample)
PT (1) PT2723774T (enExample)
RS (1) RS59021B1 (enExample)
SI (1) SI2723774T1 (enExample)
SM (1) SMT201900430T1 (enExample)
TR (1) TR201909574T4 (enExample)
TW (1) TWI564010B (enExample)
WO (1) WO2012175608A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6616725B2 (ja) * 2016-03-31 2019-12-04 日本製紙株式会社 塗工紙用澱粉
AU2020206021B2 (en) 2019-01-10 2025-05-08 Pharmacosmos Holding A/S Treating iron deficiency in subjects at risk of cardiovascular adverse events and iron for the management of atrial fibrillation
CN114286682A (zh) 2019-02-09 2022-04-05 法码科思莫斯控股有限公司 治疗具有心血管不良事件风险的个体的铁缺乏以及用于治疗心房颤动的铁
JP2024529536A (ja) 2021-08-03 2024-08-06 ファーマコスモス ホールディング エー/エス コンパニオンアニマルの鉄欠乏症の治療における皮下使用のための鉄錯体化合物
CN117547549A (zh) * 2023-11-09 2024-02-13 黑龙江八一农垦大学 适用于犬arf的腹膜透析液与助清除剂的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639588A (en) * 1966-10-22 1972-02-01 Fisons Pharmaceuticals Ltd Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids
US4370476A (en) * 1979-07-17 1983-01-25 Usher Thomas C Dextran polycarboxylic acids, ferric hydroxide complexes
GB8902894D0 (en) * 1989-02-09 1989-03-30 Fisons Plc Compositions
JPH0566372A (ja) * 1991-09-10 1993-03-19 Fukui Megane Kogyo Kk 金属製眼鏡フレーム部品の製造方法
JPH0776524A (ja) * 1993-07-13 1995-03-20 Takeda Chem Ind Ltd 動物用抗貧血剤
DK172860B1 (da) * 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
DK173138B1 (da) 1998-11-20 2000-02-07 Pharmacosmos Holding As Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma
EP1762250A1 (en) * 2005-09-12 2007-03-14 Fresenius Kabi Deutschland GmbH Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine
WO2009024518A1 (en) * 2007-08-17 2009-02-26 Akzo Nobel N.V. Alkali metal salt of glutamic acid n,n-diacetic acid, a process to prepare such salt, and the use thereof
TWI469965B (zh) * 2008-12-22 2015-01-21 Ono Pharmaceutical Co 乙炔基吲哚化合物
JP5397991B2 (ja) * 2009-04-01 2014-01-22 学校法人東京農業大学 乳酸菌を用いたビタミンb12の定量方法

Also Published As

Publication number Publication date
US9631032B2 (en) 2017-04-25
SI2723774T1 (sl) 2019-08-30
HK1220218A1 (zh) 2017-04-28
HUE044428T2 (hu) 2019-10-28
CA2837784C (en) 2019-10-15
JP2018100424A (ja) 2018-06-28
TWI564010B (zh) 2017-01-01
JP6370217B2 (ja) 2018-08-08
MX2013015075A (es) 2014-04-14
SMT201900430T1 (it) 2019-09-09
CN103649128A (zh) 2014-03-19
CY1121976T1 (el) 2020-10-14
WO2012175608A1 (en) 2012-12-27
CA2837784A1 (en) 2012-12-27
CN105348401A (zh) 2016-02-24
US20140128594A1 (en) 2014-05-08
BR112013032901A2 (pt) 2017-01-24
LT2723774T (lt) 2019-08-12
US20160046733A1 (en) 2016-02-18
CN103649128B (zh) 2016-02-10
MX337682B (es) 2016-03-15
EP2723774A1 (en) 2014-04-30
PT2723774T (pt) 2019-07-15
HRP20191173T1 (hr) 2019-10-04
PL2723774T3 (pl) 2019-10-31
US9181353B2 (en) 2015-11-10
ES2733767T3 (es) 2019-12-02
TR201909574T4 (en) 2019-08-21
EP2537866A1 (en) 2012-12-26
JP2014520188A (ja) 2014-08-21
DK2723774T3 (da) 2019-07-15
EP2723774B1 (en) 2019-04-03
TW201315474A (zh) 2013-04-16

Similar Documents

Publication Publication Date Title
RS59021B1 (sr) Postupak za proizvodnju derivata hidroksietil skroba
Anirudhan et al. Novel pH switchable gelatin based hydrogel for the controlled delivery of the anti cancer drug 5-fluorouracil
CN109134459B (zh) 吡咯喹啉醌二钠盐晶体及其制备方法
CN103435715A (zh) 寡糖及其衍生物钒配合物的制备方法及其应用
CN111647100A (zh) 一种高分子量透明质酸锌的制备方法
TWI880314B (zh) 組合物及其製備方法和用途
Yang et al. Recent developments and applications of pH-responsive polymers
JPWO2013073642A1 (ja) 還元型ピロロキノリンキノンのゲル
CN104387501A (zh) 壳聚糖定位酰化缩氨基硫脲类衍生物及其制备方法
CN101029094A (zh) 一种壳聚糖盐酸盐的制备方法
JP6757016B2 (ja) 多硫酸化プロテオグリカン
CN106519071A (zh) 一种抗肿瘤药物6‑羟基亚硒酸酯化壳聚糖铜的合成方法
Moreno-Marin et al. Encapsulation of a 5FU-curcumin hybrid on bacterial nanocellulose for colorectal cancer treatment
Mardiyanto et al. THE ROLE OF TEMPERATURE AND pH IN THE SYNTHESIS OF SILVER NANOPARTICLES USING ARECA CATECHU L. SEED EXTRACT AS BIOREDUCTOR.
TW200538457A (en) Aqueous solutions comprising camptothecin
JP6786064B2 (ja) 上皮細胞増殖剤
RS65265B1 (sr) Kompleks 7-deacetilforskolina i pvp
CN110463694A (zh) 诺氟沙星金属配合物-聚烯醇复合物及其制备方法和应用
CN110028600A (zh) 一种含锍盐的乙酰化壳聚糖衍生物及其制备方法和应用
RS20080223A (sr) Sinteza, karakterizacija i farmakološka svojstva bioaktivnih kompleksa bakar(ii)-jona sa pululanom i njegovim derivatima
KR101852470B1 (ko) 약물 고정 멤브레인 및 이의 제조방법
CN106883318A (zh) 一种含铁元素壳寡糖金属配合物的合成方法
RU2660560C1 (ru) Способ получения медьсодержащих производных сульфата арабиногалактана
CN104207142B (zh) 一种补锌与排毒营养保健剂的制备方法
CN116874641A (zh) 一种含巯基酸盐的壳聚糖盐酸盐及其制备方法和应用